Concierge Medicine Today

New Centre for Cancer Drug Discovery in London – to focus on anti-evolution treatments

All treatments for cancer should be designed to prevent tumours evolving resistance, because drug-resistant tumours are what kill most people, says Paul Workman, head of the Institute of Cancer Research (ICR) in the UK. To make this happen, the ICR is setting up a £78 million Centre for Cancer Drug Discovery in London that will bring together researchers from different disciplines to focus on creating anti-evolution treatments. “We are hugely excited about it,” Workman told a press briefing at the Science Media Centre. “The biggest challenge in cancer is drug resistance.”



%d bloggers like this: